Related Experiment Video
Updated: Apr 19, 2026

Building Up a High-throughput Screening Platform to Assess the Heterogeneity of HER2 Gene Amplification in Breast Cancers
Published on: December 5, 2017
Composite encapsulated papillary carcinoma and solid papillary carcinoma.
1Department of Pathology, University of Alabama at Birmingham, Birmingham, Alabama, USA.
This study reports the first known case of composite encapsulated papillary carcinoma (EPC) and solid papillary carcinoma (SPC), two rare breast cancer variants. The findings suggest a potential shared origin for these distinct tumor types.
Area of Science:
- Oncology
- Pathology
- Breast Cancer Research
Background:
- Encapsulated papillary carcinoma (EPC) and solid papillary carcinoma (SPC) are rare subtypes of intraductal papillary carcinomas, each comprising less than 1% of all breast cancers.
- These variants are characterized by distinct histopathological features and are typically found as separate entities.
Observation:
- A composite carcinoma featuring both EPC and SPC was identified in a 73-year-old woman presenting with a high-density breast mass.
- Microscopic examination revealed intermingled areas of EPC with delicate papillae within cystic spaces and SPC with solid nests of monotonous cells.
- Immunohistochemical analysis confirmed the absence of myoepithelial cells and demonstrated neuroendocrine differentiation in the SPC component.
Findings:
- The case represents the first documented instance of a composite tumor containing both encapsulated papillary carcinoma and solid papillary carcinoma.
- Histopathological and immunohistochemical analyses confirmed the distinct morphological and cellular characteristics of both EPC and SPC components within the same lesion.
Implications:
- This unique case challenges current understanding of breast cancer classification and raises questions about the potential common carcinogenesis pathways for rare papillary carcinoma variants.
- Further research into composite tumors like this may elucidate shared developmental mechanisms and inform future diagnostic and therapeutic strategies for breast cancer.
More Related Videos
10:29Semi-automatic PD-L1 Characterization and Enumeration of Circulating Tumor Cells from Non-small Cell Lung Cancer Patients by Immunofluorescence
Published on: August 14, 2019
07:08Author Spotlight: Reprogramming Cancer Cells to iPSCs to Study Disease Progression and Treatment Targets
Published on: February 2, 2024